WHO ICTRP trial
The Role of Plasma Exchange in Enhancing Symptom Relief and Recovery in…
CTRI/2025/11/098191 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/11/098191 |
|---|---|
| Public title | The Role of Plasma Exchange in Enhancing Symptom Relief and Recovery in Neuromyelitis Optica Spectrum Disorder |
| Scientific title | Add on Therapeutic Plasma Exchange for Acute attacks of Neuromyelitis Optica Spectrum Disorder: A Randomized Controlled Trial Assessing Clinical Outcomes - NIL |
| Primary sponsor | SCB MEDICAL COLLEGE AND HOSPITAL |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: G360- Neuromyelitis optica [Devic] |
| Interventions | Intervention1: Therapeutic Plasma Exchange: 5 sessions of therapeutic plasma exchange, exchanging 1-1.5 volume, will be carried out on alternate days, over 10 days Control Intervention1: Standard Medical Therapy: Injection… |
| Registration date | Nov 28, 2025 |
| Target size | 44 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: